We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Top Sells

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$173M
2
SPG icon
Simon Property Group
SPG
+$154M
3
WELL icon
Welltower
WELL
+$114M
4
AMT icon
American Tower
AMT
+$96.9M
5
ELS icon
Equity Lifestyle Properties
ELS
+$88M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
1176
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
154
– –
KURA icon
1177
Kura Oncology
KURA
$793M
$2K ﹤0.01%
297
– –
MGTX icon
1178
MeiraGTx Holdings
MGTX
$1.08B
$2K ﹤0.01%
330
+200
+154% +$1.34K
MLYS icon
1179
Mineralys Therapeutics
MLYS
$2.32B
$2K ﹤0.01%
152
– –
OMER icon
1180
Omeros
OMER
$845M
$2K ﹤0.01%
191
– –
PHAT icon
1181
Phathom Pharmaceuticals
PHAT
$928M
$2K ﹤0.01%
260
– –
PRAX icon
1182
Praxis Precision Medicines
PRAX
$8.11B
$2K ﹤0.01%
62
– –
PRTA icon
1183
Prothena Corp
PRTA
$448M
$2K ﹤0.01%
195
– –
QURE icon
1184
uniQure
QURE
$2.75B
$2K ﹤0.01%
158
– –
RCKT icon
1185
Rocket Pharmaceuticals
RCKT
$343M
$2K ﹤0.01%
304
– –
REPL icon
1186
Replimune Group
REPL
$454M
$2K ﹤0.01%
200
– –
SAGE
1187
DELISTED
Sage Therapeutics
SAGE
$2K ﹤0.01%
239
– –
SHY icon
1188
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$2K ﹤0.01%
19
-160
-89% -$13.2K
SVRA icon
1189
Savara
SVRA
$1.08B
$2K ﹤0.01%
553
– –
TBPH icon
1190
Theravance Biopharma
TBPH
$873M
$2K ﹤0.01%
215
– –
TKNO icon
1191
Alpha Teknova
TKNO
$266M
$2K ﹤0.01%
+300
New +$2.22K
TRVI icon
1192
Trevi Therapeutics
TRVI
$2.57B
$2K ﹤0.01%
+305
New +$1.46K
TYRA icon
1193
Tyra Biosciences
TYRA
$1.85B
$2K ﹤0.01%
+173
New +$2.24K
URGN icon
1194
UroGen Pharma
URGN
$1.97B
$2K ﹤0.01%
160
– –
XERS icon
1195
Xeris Biopharma Holdings
XERS
$1.45B
$2K ﹤0.01%
404
– –
XNCR icon
1196
Xencor
XNCR
$1.45B
$2K ﹤0.01%
222
– –
AVBP icon
1197
ArriVent BioPharma
AVBP
$1.4B
$2K ﹤0.01%
111
– –
LENZ
1198
LENZ Therapeutics
LENZ
$179M
$2K ﹤0.01%
91
– –
ABUS icon
1199
Arbutus Biopharma
ABUS
$847M
$1K ﹤0.01%
395
– –
ALT icon
1200
Altimmune
ALT
$568M
$1K ﹤0.01%
235
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.